Su-Chen Lee1, Shih-Meng Tsai2, Ming-Feng Hou3, Li-Ying Tien4, Szu-Hsien Wu5, Lisa Ann Hou6, Joseph M Tsai7, Li-Yu Tsai8. 1. Department of Laboratory Medicine, Faculty of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan. 2. Department of Public Health and Environmental Medicine, Faculty of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan. 3. Department of Surgery and Faculty of Medicine, Kaohsiung Medical University Hospital and Kaohsiung Medical University, Kaohsiung, Taiwan. 4. Division of General Laboratory, Department of Laboratory Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan. 5. Division of Plastic Surgery and Department of Surgery, Taipei Veterans General Hospital and Yang Ming University, Taipei, Taiwan. 6. Herman Ostrow School of Dentistry, University of Southern California, Los Angeles, California. 7. University of California San Diego, La Jolla, California. 8. Department of Medical Laboratory Science and Biotechnology, College of Health Sciences, Kaohsiung Medical University, Kaohsiung, Taiwan.
Abstract
BACKGROUND: In most research, there were positive associations between the insulin-like growth factor I (IGF-I) status, including IGF-I, insulin-like growth factor binding protein-3 (IGFBP-3), and ratio of IGF-I/IGFBP-3, and risks of breast cancer (BC), which was influenced by many factors, including hormone statuses and ethnicity. Therefore, the alterations of the IGF-I status in Taiwanese women with BC by menopausal statuses and hormone receptors were investigated. METHODS: The levels of IGF-I and IGFBP-3 were determined by the enzyme-labeled chemiluminescent immunometric assay, and the protein expression of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor 2 (HER2) on paraffin-embedded sections of tissues with BC were analyzed by the immunohistochemical method. RESULTS: The ratios of IGF-I/IGFBP-3 were significantly higher in the women with BC than those in the controls, but not of the levels of IGF-I and IGFBP-3; furthermore, the significantly higher ratios were found only in the postmenopausal status. In addition, there was no significant difference between the IGF-I status and ER and PR statuses, and HER2 expression, respectively, in the women with BC. CONCLUSIONS: The ratios of IGF-I/IGFBP-3 were increased in postmenopausal Taiwanese women with BC, irrespective of their ages, ER and PR statuses, and HER2 expression.
BACKGROUND: In most research, there were positive associations between the insulin-like growth factor I (IGF-I) status, including IGF-I, insulin-like growth factor binding protein-3 (IGFBP-3), and ratio of IGF-I/IGFBP-3, and risks of breast cancer (BC), which was influenced by many factors, including hormone statuses and ethnicity. Therefore, the alterations of the IGF-I status in Taiwanese women with BC by menopausal statuses and hormone receptors were investigated. METHODS: The levels of IGF-I and IGFBP-3 were determined by the enzyme-labeled chemiluminescent immunometric assay, and the protein expression of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor 2 (HER2) on paraffin-embedded sections of tissues with BC were analyzed by the immunohistochemical method. RESULTS: The ratios of IGF-I/IGFBP-3 were significantly higher in the women with BC than those in the controls, but not of the levels of IGF-I and IGFBP-3; furthermore, the significantly higher ratios were found only in the postmenopausal status. In addition, there was no significant difference between the IGF-I status and ER and PR statuses, and HER2 expression, respectively, in the women with BC. CONCLUSIONS: The ratios of IGF-I/IGFBP-3 were increased in postmenopausal Taiwanese women with BC, irrespective of their ages, ER and PR statuses, and HER2 expression.
Authors: Harriet Johansson; Laura Baglietto; Aliana Guerrieri-Gonzaga; Bernardo Bonanni; Frederique Mariette; Debora Macis; Davide Serrano; Maria Teresa Sandri; Andrea Decensi Journal: Breast Cancer Res Treat Date: 2004-11 Impact factor: 4.872
Authors: Benjamin B E Barnes; Jenny Chang-Claude; Dieter Flesch-Janys; Ralf Kinscherf; Martina Schmidt; Tracy Slanger; Gabriel Bonaterra; Karen Steindorf Journal: Cancer Causes Control Date: 2009-12 Impact factor: 2.506
Authors: Nicole M Probst-Hensch; Hao Wang; Victor H H Goh; Adeline Seow; Hin-Peng Lee; Mimi C Yu Journal: Cancer Epidemiol Biomarkers Prev Date: 2003-08 Impact factor: 4.254
Authors: G De Pergola; M Zamboni; N Pannacciulli; E Turcato; F Giorgino; F Armellini; F Logoluso; M Sciaraffia; O Bosello; R Giorgino Journal: Obes Res Date: 1998-11
Authors: Jay H Fowke; Charles E Matthews; Herbert Yu; Qiuyin Cai; Sarah Cohen; Maciej S Buchowski; Wei Zheng; William J Blot Journal: Endocr Relat Cancer Date: 2010-01-29 Impact factor: 5.678
Authors: K D Crew; T Xiao; P S Thomas; M B Terry; M Maurer; K Kalinsky; S Feldman; L Brafman; S R Refice; D L Hershman Journal: Int J Food Sci Nutr Diet Date: 2015-02-23